0001415889-24-005098.txt : 20240223
0001415889-24-005098.hdr.sgml : 20240223
20240223173325
ACCESSION NUMBER: 0001415889-24-005098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Earnhardt Lisa D
CENTRAL INDEX KEY: 0001530893
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 24672801
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
STREET 2: C/O INTERSECT ENT, INC.
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER NAME:
FORMER CONFORMED NAME: Earnhardt Lisa
DATE OF NAME CHANGE: 20110922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02232024_100219.xml
X0508
4
2024-02-21
0000001800
ABBOTT LABORATORIES
ABT
0001530893
Earnhardt Lisa D
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
EXECUTIVE VICE PRESIDENT
0
Common shares without par value
2024-02-21
4
A
0
17240
0
A
92677
D
Option (right to buy)
116.98
2024-02-21
4
A
0
64787
0
A
2025-02-21
2034-02-20
Common Shares
64787
64787
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,595 on February 21, 2025, 21,596 on February 21, 2026, and 21,596 on February 21, 2027.
/s/ Lisa D. Earnhardt, by Jessica H. Paik, Attorney-in-Fact
2024-02-23